Stock listing
Jaguar Health, Inc.
Selected listing: 1JA0 · GETTEX · EUR · DE
Jaguar Health, Inc. (gettex:1JA0). Latest release Apr 7, 2026: Jaguar Health Reports 2025 Financials.
- Ticker
- gettex:1JA0
- Asset type
- Stock
- Exchange
- gettex
- Currency
- EUR
About Jaguar Health, Inc.
Jaguar Health, Inc. is a public company traded under the ticker 1JA0 on the German market. The company focuses on developing and commercializing innovative therapies for gastrointestinal diseases. Jaguar Health aims to improve the quality of life for patients through its unique product offerings.
Latest news from Jaguar Health, Inc.
Jaguar Health Reports 2025 Financials
April 7, 2026
Jaguar Health Announces a Special One-time Stock Dividend
February 18, 2026
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 24, 2025
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease
September 30, 2025
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
September 25, 2025
Research Jaguar Health, Inc.
Alternate listings
JAGX:NASDAQ
US · USD
Alternate listing for Jaguar Health, Inc.; the primary context on this page is 1JA0:GETTEX.
1JA0:MUN
DE · USD
Alternate listing for Jaguar Health, Inc.; the primary context on this page is 1JA0:GETTEX.
JAGX:BOATS
US · USD
Alternate listing for Jaguar Health, Inc.; the primary context on this page is 1JA0:GETTEX.
1JA:SWB
DE · EUR
Alternate listing for Jaguar Health, Inc.; the primary context on this page is 1JA0:GETTEX.